medRxivGenetic & Genomic MedicinePreprint
A Bayesian model for quantifying genomic variant evidence sufficiency in Mendelian disease
- Citations
- 0
Abstract
SummaryClinical genomic interpretation depends on heterogeneous evidence checks that vary across institutions and pipelines. This variation prevents evidence from being compared or verified in a reliable way. We address this logistical barrier by introducing a universal, verifiable layer that evaluates the completeness of available scientific evidence independently of upstream analytic systems. Quantitative Evidence Sufficiency (Quant ES) summarises, for each variant, how much verifiable evidence is available using a binary matrix derived from registered rule sets. A closed form Beta Binomial model produces a single evidence sufficiency estimate with a credible interval and genome wide percentile. This separates evidence availability from provider-specific logic and enables consistent interpretation and reuse of results across institutions. ImplementationQuantBayes implements the method as compiled C binaries and an R package. It requires no access to proprietary algorithms and scales to millions of variants, allowing integration into existing diagnostic and research workflows without modification to upstream systems. AvailabilityThe QuantBayes software releases for macOS and Linux are at https://doi.org/10.5281/zenodo.17919369. The QuantBayes R package is on the Comprehensive R Archive Network (CRAN) https://doi.org/10.32614/CRAN.package.quantbayes. All releases are under the MIT licence. Graphical abstractGenomic analyses produce candidate variants, but the completeness of their supporting evidence is not directly comparable across institutions. Quant Evidence Sufficiency operates on a binary evidence matrix to summarise how much verifiable scientific evidence is available for each variant. This separates analysis outputs from interpretation and delivers an interpretable, uncertainty-calibrated measure of credibility that can be shared and reused without exposing provider-specific methods or intellectual property. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=73 SRC="FIGDIR/small/25341503v3_ufig1.gif" ALT="Figure 1"> View larger version (20K): org.highwire.dtl.DTLVardef@2a7640org.highwire.dtl.DTLVardef@1b9808eorg.highwire.dtl.DTLVardef@1a721e2org.highwire.dtl.DTLVardef@1a1ad7d_HPS_FORMAT_FIGEXP M_FIG C_FIG
- assay: whole-exome sequencing
- research focus: variant effect prediction
- research focus: benchmarking
- research focus: software / tool
- approach: Bayesian inference
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Beyond thresholds: a fully Bayesian framework for quantifying allele count evidence for variant pathogenicity
Fedor A. Konovalov·bioRxiv·Feb 10, 2026
- Calibration and refinement of ACMG/AMP criteria for variant classification with BayesQuantify
Sihan Liu, Xiaoshu Feng, … Fengxiao Bu·Journal of Medical GeneticsPeer-reviewed·Sep 19, 2025
- A novel PS4 criterion approach based on symptoms of rare diseases and in-house frequency data in a Bayesian framework.
You Kyung Cho, Dhong‐gun Won, … Byung‐Chul Lee·bioRxiv·Jul 22, 2020
- Quantifying prior probabilities for disease-causing variants reveals the top genetic contributors in inborn errors of immunity
Quant Group, Simon Boutry, … Dylan Lawless·medRxiv·Mar 25, 2025
- The PS4-Likelihood Ratio Calculator: Flexible allocation of evidence weighting for case-control data in variant classification
Charlie F Rowlands, Alice Garrett, … CanVIG-UK·Journal of Medical GeneticsPeer-reviewed·Sep 3, 2024
- Language models reveal evidence gaps in variants of uncertain significance
Weijiang Li, Vineel Bhat, … Christopher A. Cassa·medRxiv·Mar 2, 2026